144Filing Date: Aug 6, 2026
Charles River (CRL)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001969223-26-000852
Sale Plan
Michael Knell
Officer·Charles River
Proposed
Common StockNYSE
Shares6.64K
Est. DateAug 6
Market Value$1.73M
BrokerUBS Financial Services Inc
AcquisitionRSUs & PSUs · Charles River Laboratories International, Inc.
Acquired DateJan 28, 2022
Amount Acquired4.30K
% Outstanding0.0138%
Exercise / Payment Details
Paid: Aug 6, 2026Method: Cash
Signature & Compliance expand_more
Notice DateAug 6, 2026
Signature /s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Michael Knell
Issuer Info expand_more
CompanyCharles River Laboratories International, Inc.
CIK0001100682
SEC File No.001-15943
Phone4242153534
Address251 Ballardvale Street, Wilmington, MA 01887